Q3 2017 Holdings
Filed 2017-11-14 | 6 holdings | $99.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Urogen Pharma Ltd.(URGN) | Common Stock | M96088105 | $45.7K | 1,449,745 | 45.8% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common Stock | 00847L100 | $22.6K | 5,062,363 | 22.6% |
| Mersana Therapeutics, Inc. | Common Stock | 59045L106 | $16.5K | 955,709 | 16.6% |
| Immune Design Corp. | Common Stock | 45252L103 | $14.6K | 1,413,280 | 14.7% |
| Eagle Pharmaceuticals, Inc.(EGRX) | Common Stock | 269796108 | $404 | 6,777 | 0.4% |